1OLSEN N J, STEIN C M. New drugs for rheumatoid arthritis[J]. N Engl J Med,2004,350(21) :2167-2179.
2GARRISON L, McDONNELL N D. Etanercept: therapeutic use in patients with rheumatoid arthritis[J]. Ann Rheum Dis,1999,58(Suppl 1) : 165-169.
3D′Haens DR.Infliximab as disease-modifying therapy[].European Journal of Gastroenterology and Hepatology.2003
4Maini R,St Clair EW,Breedveld F,et al.Infliximab (chimeric anti-tumour necrosis factor a monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomized phase III trial[].The Lancet.1999
5LipskyPE,vanderHei jdeDMFM,StCla irE W,etal.Infli xi mab andmethotr ex ateinthetr eat-mentofr heuma toidarthritis[].The New England Journal of Medicine.2000
6Harriman G,Harper LK,Schaible TF.Summary of clinical trials in rheumatoid arthritis using infliximab,an anti-TNF alpha treatment.[].Annals of the Rheumatic Diseases.1999
7Maini,RN,Breedveld,FC,Kalden,JR.Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate[].Arthritis and Rheumatism.2004
8Van der Heijde D,Dijkmans B,Geusens P,et al.Efficacy and safety of infliximab in patients with ankylosing spondylitis: Results of a randomized, placebo-controlled trial (ASSERT)[].Arthritis and Rheumatism.2005
9Antoni C,Kavanaugh A,Kirkham B,et al.Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis:results from the infliximab multinational psori-atic arthritis controlled trial(IMPACT)[].Arthritis and Rheumatism.2005
4Emery P, Fleischmann R, Filipowicz-Sosnowska A, et al. The efficacy and safety of rituximab in patients with ac- tive rheumatoid arthritis despite methotrexate treatment results of a phase 1I B randomized, double blind, placebo controlled,dose-ranging tria[J]. Arthritis Rheum, 2006, 54(5) : 1390-1400.
